QIAGEN N.V. (NYSE: QGEN) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Mergers and Acquisitions

Qiagen (QGEN) Tops Q4 EPS by 2c, Beats on Revenues; 'Sets FY18 Outlook for Further Growth in Adj. Net Sales & Adj. EPS'January 31, 2018 4:15 PM QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease TestingJanuary 31, 2018 4:10 PM Goldman Sachs Views Lab Stocks as Attractive, Neutral on Diagnostics; LabCorp (LH) Top Pick, Myriad (MYGN) the BottomJanuary 29, 2018 12:41 PM Goldman Sachs Starts Qiagen NV (QGEN) at BuyJanuary 29, 2018 4:49 AM